(Q35873752)

10 August 2017

1 reference

title

Ocular neovascularisation and excessive vascular permeability (English)

1 reference

10 August 2017

1 reference

Peter A Campochiaro

1

1 reference

PubMed ID

15335307

10 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

Expert Opinion on Biological Therapy

10 August 2017

1 reference

10 August 2017

4

1 reference

10 August 2017

9

1 reference

10 August 2017

1395-1402

1 reference

The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking

10 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Macular oedema: the role of soluble mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Supplemental oxygen improves diabetic macular edema: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Angiopoietin-1 protects the adult vasculature against plasma leakage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood-retinal barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Angiopoietin-2 enhances retinal vessel sensitivity to vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Neuropilin is a semaphorin III receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Neuropilin is a receptor for the axonal chemorepellent Semaphorin III

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Plexin A is a neuronal semaphorin receptor that controls axon guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Systemically expressed soluble Tie2 inhibits intraocular neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Periocular Injection of Microspheres Containing PKC412 Inhibits Choroidal Neovascularization in a Porcine Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Drug targeting to specific vascular sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.9.1395

10.1517/14712598.4.9.1395

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15335307